28.43
price down icon0.25%   -0.07
after-market Dopo l'orario di chiusura: 28.43
loading
Precedente Chiudi:
$28.50
Aprire:
$28.45
Volume 24 ore:
386.84K
Relative Volume:
0.67
Capitalizzazione di mercato:
$1.35B
Reddito:
$723.55M
Utile/perdita netta:
$157.72M
Rapporto P/E:
9.4767
EPS:
3
Flusso di cassa netto:
$170.15M
1 W Prestazione:
+0.49%
1M Prestazione:
-9.72%
6M Prestazione:
-40.80%
1 anno Prestazione:
-35.25%
Intervallo 1D:
Value
$28.23
$28.71
Intervallo di 1 settimana:
Value
$27.80
$28.83
Portata 52W:
Value
$25.89
$53.95

Amphastar Pharmaceuticals Inc Stock (AMPH) Company Profile

Name
Nome
Amphastar Pharmaceuticals Inc
Name
Telefono
909-980-9484
Name
Indirizzo
11570 SIXTH STREET, RANCHO CUCAMONGA, CA
Name
Dipendente
2,028
Name
Cinguettio
Name
Prossima data di guadagno
2024-12-06
Name
Ultimi documenti SEC
Name
AMPH's Discussions on Twitter

Confronta AMPH con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Drug Manufacturers - Specialty & Generic icon
AMPH
Amphastar Pharmaceuticals Inc
28.43 1.35B 723.55M 157.72M 170.15M 3.00
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
163.11 73.07B 9.26B 2.49B 2.30B 5.47
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
15.05 47.43B 30.25B 1.37B 5.08B 0.4257
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
10.24 45.72B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
15.08 17.28B 16.54B -1.64B 749.00M -1.45
Drug Manufacturers - Specialty & Generic icon
ITCI
Intra Cellular Therapies Inc
131.81 14.03B 612.78M -86.37M -62.91M -0.87

Amphastar Pharmaceuticals Inc Stock (AMPH) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-02-04 Downgrade Piper Sandler Overweight → Neutral
2024-11-22 Iniziato Wells Fargo Equal Weight
2024-03-05 Iniziato JP Morgan Overweight
2023-11-17 Iniziato BofA Securities Neutral
2023-07-25 Ripresa Jefferies Buy
2022-10-21 Ripresa Jefferies Buy
2022-07-29 Iniziato CapitalOne Overweight
2022-01-07 Aggiornamento Piper Sandler Neutral → Overweight
2021-01-08 Downgrade Wells Fargo Overweight → Equal Weight
2020-10-05 Aggiornamento Northland Capital Market Perform → Outperform
2020-05-01 Iniziato Northland Capital Outperform
2019-03-13 Downgrade Needham Buy → Hold
2019-03-13 Downgrade Piper Jaffray Overweight → Neutral
2018-08-10 Reiterato Needham Buy
2018-03-13 Reiterato Needham Buy
2017-12-01 Reiterato Needham Buy
2017-11-09 Downgrade Raymond James Outperform → Mkt Perform
2017-09-27 Reiterato Needham Buy
2017-03-14 Downgrade Raymond James Strong Buy → Outperform
2016-08-09 Reiterato Needham Buy
2016-05-10 Reiterato Needham Buy
2016-02-19 Iniziato Wells Fargo Outperform
2015-06-19 Reiterato Needham Buy
2015-06-03 Iniziato Raymond James Strong Buy
2014-07-21 Iniziato Needham Buy
Mostra tutto

Amphastar Pharmaceuticals Inc Borsa (AMPH) Ultime notizie

pulisher
Mar 30, 2025

Raymond James Financial Inc. Takes $3.45 Million Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat

Mar 30, 2025
pulisher
Mar 29, 2025

Quantbot Technologies LP Invests $945,000 in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat

Mar 29, 2025
pulisher
Mar 29, 2025

(AMPH) Investment Report - Stock Traders Daily

Mar 29, 2025
pulisher
Mar 28, 2025

Fox Run Management L.L.C. Takes $688,000 Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat

Mar 28, 2025
pulisher
Mar 28, 2025

International Medication Systems, Ltd. Receives FDA's Drug Shortage Assistance Award - ACCESS Newswire

Mar 28, 2025
pulisher
Mar 28, 2025

Amphastar Wins FDA Award: How Its Solution to Critical Drug Shortage Signals Major Growth - StockTitan

Mar 28, 2025
pulisher
Mar 26, 2025

Intech Investment Management LLC Increases Stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat

Mar 26, 2025
pulisher
Mar 25, 2025

Piper Sandler Cuts Amphastar Pharmaceuticals (NASDAQ:AMPH) Price Target to $32.00 - MarketBeat

Mar 25, 2025
pulisher
Mar 24, 2025

Boston Partners Purchases Shares of 426,636 Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat

Mar 24, 2025
pulisher
Mar 24, 2025

Hypoglycemia Pipeline 2025: FDA Approvals, Therapies, - openPR

Mar 24, 2025
pulisher
Mar 24, 2025

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Acquired by PNC Financial Services Group Inc. - Defense World

Mar 24, 2025
pulisher
Mar 23, 2025

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Purchased by Amundi - MarketBeat

Mar 23, 2025
pulisher
Mar 23, 2025

Connor Clark & Lunn Investment Management Ltd. Cuts Stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat

Mar 23, 2025
pulisher
Mar 23, 2025

Piper Sandler Lowers Amphastar Pharmaceuticals (NASDAQ:AMPH) Price Target to $32.00 - Defense World

Mar 23, 2025
pulisher
Mar 22, 2025

Charles Schwab Investment Management Inc. Sells 2,544 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World

Mar 22, 2025
pulisher
Mar 22, 2025

Amphastar stock target cut to $32 by Piper Sandler, maintains neutral - Investing.com Canada

Mar 22, 2025
pulisher
Mar 21, 2025

Victory Capital Management Inc. Sells 155,144 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat

Mar 21, 2025
pulisher
Mar 20, 2025

Amundi Acquires 12,899 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World

Mar 20, 2025
pulisher
Mar 19, 2025

Amphastar Pharmaceuticals Inc (AMPH) Shares Up 0.46% on Mar 19 - GuruFocus.com

Mar 19, 2025
pulisher
Mar 19, 2025

US Bancorp DE Has $31,000 Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World

Mar 19, 2025
pulisher
Mar 18, 2025

(AMPH) Pivots Trading Plans and Risk Controls - Stock Traders Daily

Mar 18, 2025
pulisher
Mar 17, 2025

On Nasdaq, I Prefer The Less-Famous Stocks - Forbes

Mar 17, 2025
pulisher
Mar 16, 2025

Amphastar Pharmaceuticals (NASDAQ:AMPH) Hits New 52-Week LowTime to Sell? - MarketBeat

Mar 16, 2025
pulisher
Mar 15, 2025

Wealthfront Advisers LLC Acquires New Stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat

Mar 15, 2025
pulisher
Mar 13, 2025

Smartleaf Asset Management LLC Increases Stock Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World

Mar 13, 2025
pulisher
Mar 13, 2025

Q4 Earnings Highs And Lows: Amphastar Pharmaceuticals (NASDAQ:AMPH) Vs The Rest Of The Generic Pharmaceuticals Stocks - Yahoo Finance

Mar 13, 2025
pulisher
Mar 13, 2025

Q4 Earnings Highs And Lows: Amphastar Pharmaceuticals (NASDAQ:AMPH) Vs The Rest Of The Generic Pharmaceuticals Stocks | FinancialContent - Financial Content

Mar 13, 2025
pulisher
Mar 13, 2025

Amphastar stock hits 52-week low at $26.97 amid market challenges - Investing.com Australia

Mar 13, 2025
pulisher
Mar 12, 2025

Amphastar at Barclays Conference: Strategic Focus on Growth and Innovation By Investing.com - Investing.com UK

Mar 12, 2025
pulisher
Mar 12, 2025

Amphastar stock hits 52-week low at $26.97 amid market challenges By Investing.com - Investing.com South Africa

Mar 12, 2025
pulisher
Mar 10, 2025

Insider Selling: Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) CFO Sells 4,231 Shares of Stock - MarketBeat

Mar 10, 2025
pulisher
Mar 08, 2025

Amphastar Pharmaceuticals Inc to Host Earnings Call - ACCESS Newswire

Mar 08, 2025
pulisher
Mar 08, 2025

(AMPH) Proactive Strategies - Stock Traders Daily

Mar 08, 2025
pulisher
Mar 07, 2025

Amphastar Pharmaceuticals director Petersen sells $27,986 in stock By Investing.com - Investing.com South Africa

Mar 07, 2025
pulisher
Mar 07, 2025

Amphastar Pharmaceuticals director Petersen sells $27,986 in stock - Investing.com India

Mar 07, 2025
pulisher
Mar 07, 2025

Amphastar Pharmaceuticals, Inc. to Host Earnings Call - ACCESS Newswire

Mar 07, 2025
pulisher
Mar 07, 2025

Amphastar Pharmaceuticals CFO sells $116,515 in stock By Investing.com - Investing.com Australia

Mar 07, 2025
pulisher
Mar 06, 2025

Amphastar Pharmaceuticals CFO sells $116,515 in stock - Investing.com

Mar 06, 2025

Amphastar Pharmaceuticals Inc Azioni (AMPH) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$10.41
price down icon 3.70%
$33.21
price down icon 0.95%
$96.16
price down icon 0.91%
$8.68
price down icon 1.81%
$113.16
price down icon 0.74%
$131.81
price up icon 0.05%
Capitalizzazione:     |  Volume (24 ore):